Board of Directors

, ANZUP

Board of Directors 2018

ANZUP’s Board is responsible for financial management, corporate governance, reporting and compliance. The Board of Directors is comprised of healthcare professionals as well as representatives from both the business and patient sector. All are committed to providing strategic direction and oversight to ensure ANZUP’s ongoing growth, significance and sustainability. Each board member is passionate about ANZUP’s work, and undertake their role in a voluntary capacity.

, ANZUP

Ian Davis, Chair

Professor Ian Davis is chair of the ANZUP Board and of its Scientific Advisory Committee. He is a medical oncologist and Professor of Medicine and Head of the Eastern Health Clinical School, Monash University and Eastern Health, in Melbourne, Australia. He holds honorary appointments with the Olivia Newton-John Cancer Research Institute and Austin Health, is an Associate Professor of the University of Melbourne, and Associate of the University of Sydney. His primary clinical interests are in urologic cancers, and his primary research interests are in cancer immunology and the biology of urologic cancers. Prof Davis is a member of the Medical & Scientific Committee and of the Standing Subcommittee on Research for the Cancer Council Victoria. He founded the Urologic Oncology Group of the Clinical Oncology Society of Australia (COSA), is a member of COSA Council, and was previously a COSA Board director.

, ANZUP

Joe Esposito, Deputy Chair

Mr Joe Esposito is a Melbourne based director who has recently established a business consultancy practice, Grumentum Capital Pty Ltd. For 8 years until 2020, he owned and operated a BOQ (Bank of Queensland) branch in the inner city suburb of Collingwood. He has had over 20 years experience in corporate banking in Australia and New Zealand. Between 2003 and 2006 he was the CEO of ASX listed Jetset Travelworld Limited.
Mr Esposito has a close affinity with the objectives of ANZUP and the needs of cancer consumers. His qualifications include a Bachelor of Commerce, a Master of Applied Finance and a Diploma in Finance and Mortgage Management. He is a graduate member of the Australian Institute of Company Directors.

, ANZUP

Nick Buchan

Dr Nick Buchan is a Urologist based in Christchurch, New Zealand and works in both public and private practice. Nicks practice focuses on the diagnosis and management of urological cancers. Nick gained his experience in medical trials while on fellowship at the Vancouver Prostate Centre. The Vancouver Prostate Centre is one of the largest research and clinical centres in the world that focuses on translational research into prostatic diseases, prostate cancer in particular. Currently Nick is managing director of the Canterbury Urology Research Trust (CURT). CURT is a trust that conducts urological trials for contract research organisations (CROs) as well as its own investigator lead trials in urological conditions with the main focus being urological oncology. Nick is also a previous director of a privately owned hospital in Christchurch, Forte Health and managing director of a large Urology specialist practice, Urology Associates.

, ANZUP

Martin Dowling

Mr Martin Dowling has held executive and senior management level financial and commercial roles at some of the largest companies in the world. He has delivered in leadership roles against a broad portfolio of responsibilities across a range of industries including mining, mining services, manufacturing and engineering. He has a Bachelor of Commerce and MBA degree and is a Fellow of CPA Australia and a graduate member of the Australian Institute of Company Directors. He is committed to the pursuit of charitable and societal goals as a Director on not-for-profit boards and also actively in the local community.

, ANZUP

Glenn Ferguson

Mr Glenn Ferguson AM is a Solicitor of the High Court of Australia and the Supreme Court of Queensland. He is a past President of the Law Council of Australia and past President of Lawasia the law association for Asia and the Pacific and a past President of the Queensland Law Society. He is also a Senior Counsellor with the Queensland Law Society and has previously chaired their professional standards committee. Glenn is a Founding Fellow of the Australian Academy of Law, a Fellow of the Australian Institute of Company Directors and a Fellow of the Australia and New Zealand College of Notaries. He was appointed the inaugural Adjunct Professor in Law at the University of the Sunshine Coast. He is currently Chair Lexon Insurance and a Governor of the College of Law. He has been appointed by both Federal and State Governments to various advisory boards and task forces in the legal, business and immigration sectors. In the 2015 Australia Day Honours, Glenn was made a Member of the Order of Australia “For significant service to the law and to the legal profession, both nationally and in the Asia Pacific region, and to the community”.

, ANZUP

Lisa Horvath

Professor Lisa Horvath is the Director of Research at Chris O’Brien Lifehouse. She completed medical school at the University of Sydney and trained in medical oncology at Royal Prince Alfred Hospital, where she was appointed to the senior staff in 2003. She completed her PhD in translational research at the Garvan Institute of Medical Research in 2004. Lisa’s research interest is predominantly in the field of prostate cancer in particular biomarkers, prostate cancer biology and clinical trials.
Lisa holds academic appointments at both the University of Sydney and the University of New South Wales and is the Head of Advanced Prostate Cancer research group at The Kinghorn Cancer Centre/Garvan Institute of Medical Research. She is the Conjoint Chair of Medical Oncology (Genitourinary Cancers) at Lifehouse. She has published more than 100 original research papers in peer-reviewed journals in the last 20 years. She has presented extensively at national and international meetings both peer-reviewed and invited presentations. Lisa is an ANZUP Board Director, a member of the ANZUP Scientific Advisory Committee and is Chair of the ANZUP Prostate Cancer Subcommittee.

, ANZUP

Linda Martin

Ms Linda Martin has recently retired after a broad career in Executive roles spanning public, private and not for profit organisations. She was previously CEO of not for profit Musculoskeletal Australia, a Senior Executive in the Victorian Public Service, working primarily in the health and community service sectors in large scale operational and project roles and a senior consultant in a strategic branding and marketing company. As Managing Director of a management consultancy firm she worked in diverse industries including banking, insurance, health, aged care, disability and transport sectors. Her work as an Executive coach and mentor continues. Linda has also been a lecturer in Social Work at the University of Melbourne, an industry representative on the Monash University, School of Public Health and Preventive Medicine Postgraduate Courses Committee and a Board Director of QEC. Linda’s focus has been on governance, strategic and business planning and reform and the development of strategic alliances. She is passionate about achieving consumer outcomes in health.

, ANZUP

Shomik Sengupta

Professor Shomik Sengupta is Professor of Surgery and deputy Head of School at the Eastern Health Clinical School, Monash University and a consultant urologist and Uro-Oncology lead at the Department of Urology, Eastern Health. Shomik has a practice with a urooncology subspecialty interest – including open, laparoscopic and robotic cancer surgery. Shomik also has a strong interest in urologic research, including involvement in clinical trials through the Australian and New Zealand Urogenital & Prostate (ANZUP) Cancer Trials Group, where he is a member of the Board and the Scientific Advisory Committee. Shomik has more than 100 original publications to date and has been an invited speaker, session chair and convenor at numerous scientific meetings.

, ANZUP

Henry Woo

Professor Henry Woo is a urological surgeon who subspecialises in prostate disease. He is the Director of Uro-Oncology and Professor of Robotic Cancer Surgery at the Chris O’Brien Lifehouse. He is also Professor of Surgery at the Sydney Adventist Hospital Clinical School of the University of Sydney. He has published widely in major urological journals. He is an Associate Editor of the journal Prostate Cancer Prostatic Diseases and serves on the journal editorial boards of European Urology, BJUI, Prostate International, Asian Journal of Urology and World Journal of Men’s Health. He also serves on the board of the charitable Australian Urological Foundation(AUF) and is a member of the Executive Committee of the Asian Pacific Prostate Society (APPS). He is passionate about clinical trials and procuring the best evidenced based options for his patients. He also has particular interests in surgical education and the role of social media in learning and health advocacy.

, ANZUP

Margaret McJannett, CEO Ex-officio

Ms Margaret McJannett is the Chief Executive Officer (CEO) for ANZUP Cancer Trials Group Ltd. Her professional background is in nursing with a post-graduate certificate in oncology nursing. Margaret worked as a clinical nurse consultant at The Sydney Melanoma Unit, research coordinator in the Medical Psychology Research Unit, Sydney University and project officer at the Queensland Institute of Medical Research in Brisbane. Ms McJannett more recently was the EO of the Clinical Oncological Society of Australia (COSA) and Cancer Council Australia before taking up her role with ANZUP. She has facilitated and contributed to COSA's and CCA's expert committees, the national Cancer Co-operative Clinical Trials Groups and COSA's collaborative role with key stakeholders including other NGO's Cancer Voices, Government agencies and Industry partners.